At a Glance
| Oxiracetam | Adrafinil | |
|---|---|---|
| Class | Stimulants, Nootropic | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 1200–1800 mg | 250–400 mg |
| Total Duration | 0.5–1.5 hrs | 6.3–9 hrs |
| Routes | oral | oral |
| Effects | 8 documented | 9 documented |
Oxiracetam, a Stimulants, Nootropic, and Adrafinil, a Stimulants, Nootropic, Eugeroics, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Oxiracetam is classified as a Stimulants, Nootropic while Adrafinil is a Stimulants, Nootropic, Eugeroics, meaning they approach altered states through different pharmacological mechanisms. They share 5 documented effects in common, with 3 effects unique to Oxiracetam and 4 unique to Adrafinil. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Oxiracetam | Adrafinil | |
|---|---|---|
| Class | Stimulants, Nootropic | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 1200–1800 mg | 250–400 mg |
| Total Duration | 0.5–1.5 hrs | 6.3–9 hrs |
| Routes | oral | oral |
| Effects | 8 documented | 9 documented |
| Interaction |
| Caution |
| Level | Oxiracetam | Adrafinil |
|---|---|---|
| Threshold | 250 mg | 100 mg |
| Light | 500–1200 mg | 150–250 mg |
| Common | 1200–1800 mg | 250–400 mg |
| Strong | 1800–2400 mg | 400–600 mg |
| Heavy | 2400 mg | 600 mg |
Oxiracetam
Adrafinil
Increased cardiovascular strain and neurotoxicity risk